GENE ONLINE|News &
BIOAsia-Taiwan a premier, must-attend conference for the entire Asia-Pacific region
Taiwan is a global powerhouse in technology IT and computing systems. As biotech evolves, we are creating new products that marry breakthroughs like artificial intelligence with big data derived from the human genome, that’s why Taiwan is uniquely situated to play an integral role in the future of our industry. – Jim Greenwood, President, and CEO of BIO.
In 2019, BIO Asia Taiwan will bring together cutting-edge innovators and investors from across North America, Europe and Asia to explore business opportunities with Taiwan’s emerging biotech sector. This is a premier must-attend conference for the entire Asia-pacific region.
Contact:
BIO Asia-Taiwan 2019 Secretariat
email: register@taiwanbio.org.tw
website: www.bioasiataiwan.com
Author
LATEST
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
Takeda, Astellas, and Sumitomo Mitsui Banking Declare Agreement For Early Drug Discovery Program Incubation in Joint Venture
2024-04-23
EVENT
2024-04-27
2024 Biomedical Final Pitch Competition
Room DA1620, Dana Building, Dana-Farber Cancer Institute, 99 Jimmy Fund Way, Boston, MA 02115
